Internal Medicine · Houston, TX
NPI
1043218845
Since 2005
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
6301 Richmond Ave Ste 101
Houston, TX, 77057
Phone (713) 961-7100
Groups this clinician bills Medicare through
Medicare paid, 2024
$600K
34,991 services
Medicare patients, 2024
720
Average age 67
Drug cost, 2024
$6.8M
39,008 prescriptions
Company payments, 2025
$1,402
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Patricia D Salvato was code 86003 (immunoassay), 14,750 times for 207 patients. In total Patricia D Salvato billed 34,991 services in 55 codes, and Medicare paid $600K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-04-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 86003 Immunoassay | Office | 14,750 | 207 | $5.09 | $75K |
| 95165 Treatment - Miscellaneous | Office | 13,710 | 90 | $11.27 | $154K |
| 99214 Office E&M - Established | Office | 1,748 | 603 | $84.54 | $148K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,023 | 496 | $12.48 | $13K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 379 | 129 | $47.14 | $18K |
| 99489 Chronic, Principal, and Transitional Care Management | Office | 348 | 95 | $57.28 | $20K |
| 99213 Office E&M - Established | Office | 313 | 203 | $59.24 | $19K |
| 99487 Chronic, Principal, and Transitional Care Management | Office | 272 | 126 | $101.72 | $28K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 248 | 50 | $0.07 | $16.54 |
| 96137 Behavioral Health Services | Office | 220 | 189 | $25.41 | $5,591 |
| 96136 Behavioral Health Services | Office | 220 | 189 | $28.60 | $6,292 |
| 82785 Immunoassay | Office | 210 | 206 | $16.06 | $3,373 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 196 | 100 | $36.91 | $7,234 |
| 95923 Electrical Nerve Conductivity | Office | 181 | 175 | $87.53 | $16K |
| 95921 Electrical Nerve Conductivity | Office | 181 | 175 | $58.71 | $11K |
By year: 2022 $709K for 26,353 services; 2023 $612K for 18,053 services; 2024 $600K for 34,991 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 86003 Immunoassay | 14,750 | 207 | $5.09 | $75K |
| 82785 Immunoassay | 210 | 206 | $16.06 | $3,373 |
| 81000 Clinical Chemistry | 72 | 52 | $3.56 | $256 |
Medicare prescription drug claims, 2024
In 2024, the drug Patricia D Salvato prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 2,594 prescriptions and refills. In total Patricia D Salvato wrote 39,008 Medicare prescriptions that cost $6.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 2,594 | 2,596 | 313 | $111K |
| Gabapentin Generic | 1,185 | 1,674 | 232 | $16K |
| Levothyroxine Sodium Generic | 1,141 | 2,332 | 251 | $10K |
| Zolpidem Tartrate Generic | 692 | 777 | 103 | $4,678 |
| Amlodipine Besylate Generic | 635 | 1,219 | 140 | $2,484 |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 626 | 672 | 99 | $20K |
| Lisinopril Generic | 618 | 1,206 | 136 | $3,034 |
| Tizanidine Hcl Generic | 595 | 834 | 99 | $11K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 586 | 589 | 78 | $29K |
| Trazodone Hcl Generic | 538 | 940 | 125 | $4,433 |
| Omeprazole Generic | 489 | 1,021 | 131 | $6,769 |
| Tramadol Hcl Generic | 461 | 467 | 76 | $5,500 |
| Hydrochlorothiazide Generic | 454 | 791 | 104 | $1,134 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 445 | 707 | 127 | $9,983 |
| Atorvastatin Calcium Generic | 435 | 938 | 112 | $2,375 |
Brand drugs: 4,540 claims; generic drugs: 34,228 claims; opioid claims: 5,053.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Patricia D Salvato $1,402 ($1,402 in general payments such as food, travel and fees) from 21 companies. The largest payer was ViiV Healthcare Company with $273.
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company GSK | 12 | $273 |
| Pfizer Inc. PFE | 9 | $149 |
| AstraZeneca Pharmaceuticals LP AZN | 6 | $149 |
| Abbvie Inc. ABBV | 25 | $146 |
| Novo Nordisk Inc NVO | 6 | $141 |
| Merck Sharp & Dohme LLC MRK | 7 | $136 |
| EMD Serono, Inc. MRK.DE | 5 | $115 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 2 | $31.84 |
| Antares Pharma, Inc. | 2 | $28.46 |
| Renalytix AI, Inc. | 1 | $27.87 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.